Drug details

Alyq (tadalafil tablets)

type of PAH, PDE-5 Inhibitors, Phosphodiesterase-5 Enzyme Inhibitors

Alyq (tadalafil) is a phosphodiesterase 5 (PDE5) inhibitor indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) to improve exercise ability. Alyq is available in generic form.

This drug may have the following side effects:

• nausea,
• headache,
• back pain, or
• runny or stuffy nose,
• indigestion
• muscle pain,
• flushing,
• pain in extremities,
• respiratory tract infection,

The following drugs are related to Alyq, either as a replacement or used together:

• Adcirca (tadalafil tablets)
• Letairis (ambrisentan tablets)
• Veletri (epoprostenol powder for intravenous administration)
• Flolan (epoprostenol sodium)
• Ventavis (iloprost)
• Opsumit (macitentan tablets)
• Remodulin (treprostinil sodium)
• Revatio (sildenafil citrate)
• Tyvaso DPI (treprostinil inhalation powder)
• Tyvaso (treprostinil inhalation solution)
• Uptravi (uptravi selexipag tablets)